Jury Finds Seizure drug Topamax Caused Cleft Birth Defects
Posted by Michael Monheit
November 22, 2013 10:55 AM
November 22, 2013 10:55 AM
The Legal Examiner Central Pennsylvania is brought to you by Anapol Weiss
Anapol Weiss
(866) 735-2792www.anapolweiss.com
130 North 18th Street
Suite 1600
Philadelphia, Pennsylvania 19103
[Show Map]
8700 East Bonita Drive
Scottsdale, Arizona 85255
[Show Map]
1040 Kings Hwy N
Cherry Hill, New Jersey 08034
[Show Map]
Olde Liberty Square
4807 Jonestown Rd
Harrisburg, Pennsylvania 17109
[Show Map]
Personal Injury Lawyers Serving:
Anapol Weiss' offices are located in Philadelphia and Harrisburg, PA, as well as New Jersey, Arizona, and Ohio.
Archives
Categories
- Automobile Accidents
- Defective & Dangerous Products
- FDA & Prescription Drugs
- Head & Brain Injuries
- Mass Transit (Airline, Cruise Ship, Train, Bus)
- Medical Devices & Implants
- Medical Malpractice
- Miscellaneous
- Motorcycle Accidents
- Nursing Home & Elder Abuse
- Property Owner's Liability (Slip & Fall)
- Spinal Cord Injuries
- Toxic Substances
- Tractor-Trailer Accidents
- Uncategorized
- Workplace Discrimination
- Workplace Injuries
- Wrongful Death
Subscribe to The Legal Examiner
Keep up with the latest updates using your favorite RSS reader

Janssen Pharmaceuticals, a unit of Johnson & Johnson, has been ordered to pay $4.02 million in a lawsuit which claims their drug Topamax, used to help patients with epilepsy, caused birth defects such as cleft palate.
Jury Finds Seizure drug Topamax Caused Cleft Birth DefectsThe jury, who deliberated for less than one hour, rendered a verdict in favor of April Czimmer, a Virginia resident who recently gave birth to a boy with a cleft lip. The boy had undregone four surgeries shortly after birth to correct the issue.
Cleft palate and cleft lip are a genetic abnormality that occur when the lip or palate fail to completely fuse together. This results in a small notch in the upper lip, or in extreme cases, a large groove from the roof of the mouth extending to the nose.
Czimmer’s attorney Tommy Fibich said that “This was our first case to go to trial and there are many more behind it…This will expose the company to many more lawsuits”.
The case is the first of almost 134 cases pending over use of the drug.
Janssen has stated that it will appearl the verdict.
“We are extremely disappointed with the jury’s verdict,” Teresa Mueller, a spokeswoman for the company said. “The evidence showed that the company clearly warned Ms. Czimmer’s prescriber that the product had the risk to cause birth defects and she understood and conveyed those warnings to Ms. Czimmer.”
Janssen insists that there are many other factors which could contrinbute to the birth defects, including genetics, smoking, and other drug use.
Czimmer was also taking an anti-anxiety drug when she became pregnant.